Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that members of the executive management team will participate in two upcoming investor conferences:

In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events" through the "Investors" section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia's website.

ABOUT AURINIA

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company has introduced LUPKYNIStm (voclosporin), the first FDA-approved oral therapy dedicated for the treatment of adult patients with active lupus nephritis (LN). The Company's head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.


These press releases may also interest you

at 00:36
Meadow Valley Meats is recalling Turkey Breakfast Sausage from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below. The following product...

18 jun 2021
The powered air purifying respirator market report offers a detailed analysis of the impact of the COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios. Technavio forecasts the market to grow by USD 638.16...

18 jun 2021
WHAT: The NAACP Houston Branch and Dr. Joseph C. Gathe, Jr., M.D. collaborate to offer free Pfizer and Moderna COVID-19 vaccinations on a first-come-first-serve basis to students, parents, and guardians in unserved and underserved Houston...

18 jun 2021
Jones Family Dental is providing notice of a recent incident that may affect the privacy of information of certain Jones Family Dental's patients. At this time, Jones Family Dental has no indication that any information has been fraudulently misused...

18 jun 2021
Inhibikase Therapeutics, Inc. (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders inside and outside of the brain, today announced the closing of its...

18 jun 2021
The modular laboratory automation market report provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The market is expected to grow by USD 1.08 billion during 2020-2024....



News published on 14 may 2021 at 06:10 and distributed by: